Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis

Cancer

Volumn 86, Issue 2, 1999, Pages 248-254

  Ueno, Shinichi ^a   Tanabe, Gen ^a   Yoshida, Aichi ^a   Yoshidome, Shinrou ^a   Takao, Sonshin ^a   Aikou, Takashi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Hepatitis activity index score; Hepatocellular carcinoma; Intrahepatic recurrence; Multicentric occurrence

Indexed keywords

CISPLATIN; MITOMYCIN;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC HEPATITIS; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER;

EID: 0033565280     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990715)86:2<248::AID-CNCR8>3.0.CO;2-1     Document Type: Article

References (23)

1. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997;25:87-92.
2. Takenaka K, Adachi E, Nishizaki T, Hiroshige K, Ikeda T, Tunetoshi M, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology 1994;19:889-94.
3. Okusaka T, Okada S, Nose H, Ishii H, Nakasuka H, Nakayama H, et al. The prognosis of patients with hepatocellular carcinoma of multicentric origin. Hepatogastroenterology 1996;43:919-25.
4. Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, et al. Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology 1992;103:595-600.
5. Chiu JH, Wu LH, Kao HL, Chang HM, Tsay SH, Loong CC, et al. Can determination of the proliferating capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma? Hepatology 1993;18:96-102.
6. Ikeda K, Saitoh S, Koide I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
7. Shirabe K, Takenaka K, Taketomi A, Kawahara N, Yamamoto K, Shimada M, et al. Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996;77:1050-5.
8. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Ann Surg 1996;224:591-5.
9. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995;108:768-75.
10. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of anumerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
11. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17
12. Yoshidome S, Tanabe G, Yoshida Y, Ueno S, Hamanoue M, Mitsue S, et al. Risk prediction using histology of non-cancerous liver before hepatic resection for hepatocellular carcinoma. Hepatogastroenterology. In press.
13. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 3rd edition. 1992:15.
14. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas. Cancer 1990;65:1104-10.
15. Faccioli S, Chieco P, Gramantieri L, Stecca BA, Bolondi L. Cytometric measurement of cell proliferation in echo-guided biopsies from focal lesions of the liver. Mod Pathol 1996;9:120-5.
16. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver disease: clinical implications. Hepatology 1995;21:106-12.
17. Loreal O, Clement B, Schuppan D, Rescan PY, Rissel M, Guillouzo A. Distribution and cellular origin of collagen IV during development and in cirrhosis. Gastroenterology 1992; 102:980-7.
18. Gaudio E, Pannarale L, Ripani M, Onori P, Riggio O. The hepatic microcirculation in experimental cirrhosis. A scanning electron microscopy study of microcorrosion casts. Scanning Microsc 1991;5:495-502.
19. Martinez Hernandez A, Amenta PS. The hepatic extracellular matrix 2 Ontogenesis, regeneration and cirrhosis. Virchows Arch A Pathol Anat Histopathol 1993;423:77-84.
20. Melato M, Laurino L, Mucli E, Valente M, Okuda K. Relationship between cirrhosis, liver cancer, and hepatic metastases. An autopsy study. Cancer 1989;64:455-9.
21. Nonami T, Isshiki K, Katoh H, Kishimoto W, Harada A, Nakao A, et al. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann Surg 1991;213:222-6.
22. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, et al. Liver resection for hepatocellular carcinoma: results of 229 consecutive patients during 11 years. Ann Surg 1993;217:375-84.
23. Lai ECS, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma. Arch Surg 1998;133:183-8.